Janux Therapeutics, Inc. JANX
CIK 0001817713
Form 4 transactions dated Oct 1, 2023 to Oct 1, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $94.01M
- Sold
- $343.99M
Oct 1, 2023 – Jul 31, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2024-12-24 | Campbell David Alan President and CEO · Director | Sale10b5-1 footnote | $1.40M 25,000 shares sold | 10.33% sold Direct holding | ▾ |
| 2024-12-03 | Campbell David Alan President and CEO · Director | Sale10b5-1 footnote | $1.00M 15,000 shares sold | 5.84% sold Direct holding | ▾ |
| 2024-11-25 | Campbell David Alan President and CEO · Director | Sale10b5-1 footnote | $1.29M 25,000 shares sold | 8.86% sold Direct holding | ▾ |
| 2024-10-28 | Campbell David Alan President and CEO · Director | Sale10b5-1 footnote | $1.34M 25,000 shares sold | 8.14% sold Direct holding | ▾ |
| 2024-10-18 | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. · RA Capital Nexus Fund II, L.P. Director · 10% owner | Purchase | $53.70M 1,200,000 shares bought | Unavailable Indirect holding | ▾ |
| 2024-10-18 | Lichter Jay · Avalon Ventures XI, L.P. · Avalon BioVentures SPV I, L.P. · Avalon BioVentures I, LP 10% owner | Sale | $30.21M 660,018 shares sold | Unavailable Direct holding | ▾ |
| 2024-10-18 | Lichter Jay · Avalon Ventures XI, L.P. · Avalon BioVentures SPV I, L.P. · Avalon BioVentures I, LP 10% owner | Sale | $5.85M 127,852 shares sold | Unavailable Indirect holding | ▾ |
| 2024-10-18 | Lichter Jay · Avalon Ventures XI, L.P. · Avalon BioVentures SPV I, L.P. · Avalon BioVentures I, LP 10% owner | Sale | $30.84M 673,899 shares sold | Unavailable Indirect holding | ▾ |
| 2024-10-17 | Lichter Jay · Avalon Ventures XI, L.P. · Avalon BioVentures SPV I, L.P. · Avalon BioVentures I, LP 10% owner | Sale | $92.19K 1,843 shares sold | Unavailable Direct holding | ▾ |
| 2024-10-16 | Lichter Jay · Avalon Ventures XI, L.P. · Avalon BioVentures SPV I, L.P. · Avalon BioVentures I, LP 10% owner | Sale | $5.04M 100,610 shares sold | Unavailable Direct holding | ▾ |
Showing 30 / 44 record groups in 2024. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 44 purchase / sale groups and 30 of 75 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"JANX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.